Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial

OBJECTIVE: To determine the occurrence of extremely low HDL cholesterol (HDL-C) among participants in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid Trial and to examine the relationship of this finding with treatment with fenofibrate and thiazolidinedione (TZD). RESEARCH DESIG...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Linz, Peter E., Lovato, Laura C., Byington, Robert P., O’Connor, Patrick J., Leiter, Lawrence A., Weiss, Daniel, Force, Rex W., Crouse, John R., Ismail-Beigi, Faramarz, Simmons, Debra L., Papademetriou, Vasilios, Ginsberg, Henry N., Elam, Marshall B.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Diabetes Association 2014
Onderwerpen:
Clinical Care/Education/Nutrition/Psychosocial Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3931389/
https://ncbi.nlm.nih.gov/pubmed/24296848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-0790
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items